ISSN: 2375-4508
Journal of Fertilization: In Vitro - IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biology
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
 
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Epigenetic Re-Programming during Mammalian Preimplantation Embryogenesis and PGC Development

Fei Teng1,2 and Qi Zhou1*
1State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
2University of Chinese Academy of Sciences, Beijing 100049, China
*Corresponding Author : Qi Zhou
1 Beichen West Road
Chaoyang District
Beijing 100101, PR China
Tel: +86-10-64807312
Fax: 86-10-64807299
E-mail: zhouqi@ioz.ac.cn
Received September 05, 2013; Accepted November 04, 2013; Published November 06, 2013
Citation: Teng Fei, Zhou Fei (2013) Epigenetic Re-Programming during Mammalian Preimplantation Embryogenesis and Pgc Development. J IVF Reprod Med Genet 1:114. doi: jfiv.1000114
Copyright: © 2013 Teng Fei, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Fertilization: In Vitro - IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biology

Abstract

Epigenetic programming and reprogramming, by means of DNA methylation and histone modifications etc., control the mammalian development to a large extent. They are also artificially altered for cell fate conversion and regeneration. Though epigenetic modifications change with slow dynamics during somatic cell lineage differentiation, they undergo a genome-wide dramatic change with extensive DNA de-methylation and histone modification during two specific time windows, the early embryogenesis and the Primordial Germ Cell (PGC) development stage. Here we reviewed these global epigenetic reprogramming occurred during normal development, mainly focusing on DNA methylation, histone modification and X-chromosome inactivation. Epigenetic reprogramming participates in many key biological processes such as genomic imprinting, X-chromosome inactivation, gene expression regulation and tumorigenesis and genome stability. Understanding the mechanisms of epigenetic reprogramming during the early embryogenesis and PGC formation would facilitate our knowledge of the developmental process and disease progress.

Keywords
Epigenetic reprogramming; DNA methylation; Demethylation; Histone modifications; X chromosome inactivation; Embryogenesis; PGCs
Abbreviations
PGCs: Primordial Germ Cells; XCI: X Chromosome Inactivation; 5mC: 5-methylcytosine; 5hmC: 5-hydroxymethylcytosine; Xp: Paternal X Chromosome; 5fC: 5-formylcytosine; 5caC: 5-carboxylcytosine; ICM: Inner Cell Mass; PRC2: Polycomb Repressive Complex 2; IAPs: Intracisternal-A-Particles; CGIs: CpG Islands; gDMRs: Germline Differently Methylated Regions; Xi: Inactive X Chromosome; qRT-PCR: Quantitative Reverse Transcription Polymerase Chain Reaction
Introduction
Epigenetic landscape, including both DNA methylation and histone modifications, is maintained in a relatively stable state in mammalian somatic issues. However, during the Preimplantation embryogenesis and the post-implantation germ cell development processes, two waves of genome-wide epigenetic programming and reprogramming occur. In these processes, DNA methylation erasure and reestablishment and histone remodeling change dynamically and cooperatively to construct the epigenome, which restores the genome to a pluripotent state and impose on the following differentiation.
In mammals, upon fertilization, the zygotic genome experiences a comprehensive reprogramming process, which contributes to the transition of the zygote into a totipotent state. And during this reprogramming process, epigenetic reprogramming plays an essential role in regulating the zygotic gene expression.
The second wave of epigenetic reprogramming starts to emerge together with the specification of PGCs at E7.25 [1]. During this process, DNA de-methylation is completed thoroughly, with the erasure of the methylation pattern in imprinted loci between E10.5 and E12.5 after they migrate into the genital ridge [2,3]. And this makes the genome ready to reset to a gender-specific state along with the mature of germ cells.
Coupling with epigenetic remodeling in females, a signature of the placental mammals-X chromosome inactivation occurs, which balances the expression dosage of genes on X chromosome between males (XY) and females (XX). Since one of the two X chromosomes in female somatic cells is transcription ally silenced, namely the X Chromosome Inactivation (XCI), the expression of X-linked genes is monoallelic. There are two forms of XCI in mice, imprinted and random ones, and their dynamics correlates with the two waves of DNA methylation variation during embryogenesis in utero.
Epigenetic reprogramming during the Preimplantation embryogenesis
DNA de methylation in the early embryogenesis: During early embryogenesis, with a global DNA de-methylation observed in mouse embryos, the DNA methylation level drops to the lowest at the blastocyst stage [4,5], which then gradually reverts to the somatic level after implantation happens due to functions of the de novo DNA methyl transferase, namely Dnmt3a and Dnmt3b [6], and maintains stable thereafter resulting from the activity of Dnmt1, the maintenance methylase. But during embryo development processes between the two-cell and the blastocyst stage, there is no Dnmt1, which results in a replication-dependent manner of gradual reduction in DNA methylation. Thus the so-called passive de-methylation occurs in the maternal genome (Figure 1) [4,7]; Whereas the paternal genome DNA is actively demethylated at the one-cell stage in a quite different pattern, that is, through the replication-independent pathway (Figure 1) [8-10]. During the de-methylation process, most genes are demethylated throughout the whole genome, including housekeeping genes and repeat sequences like LINE1. However, the imprinted genes can surprisingly escape from this fate successfully and remain hypermethylated, similar to the ones in gametes.
Though the phenomena of active and passive de-methylation are observed in the paternal and the maternal genomes respectively, the mechanisms of how active de-methylation happens and how imprinted genes are exempt from de-methylation are little known. Significant advancements have been made in deciphering the mechanisms behind active de-methylation, and the discovery of Tet proteins (Tet1, Tet2, Tet3), which catalyze the conversation of 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) [11,12], was a hallmark among them. It is demonstrated that Tet3 mediates the active de-methylation of paternal pronuclear at the one-cell stage. Researchers uncovered an inverse correlation between 5mC and 5hmC, and this conversation was carried out by Tet3, since Tet3 knockout in mouse embryos eliminated this conversation and led to embryonic development failure [13]. Meanwhile, further studies identified that the converted 5hmC was not just an intermediate, for the reason that instead of disappearing soon, they were further converted into 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) [14,15]. Moreover, they were diluted in a replication-dependent way, a similar pattern like the DNA demethylation in the maternal genome [14,16].
Histone modifications in the preimplantation embryos: Another crucial epigenetic factor influencing the development of preimplantation embryos remarkably is the modification of histones. They mark developmentally related genes and predetermine their expression before zygotic genome activation [17,18]. Increasingly more evidence suggests that a crosstalk between histone modifications and DNA methylation exists. Early studies demonstrated that there are changes of histone modification patterns happened along with the development of pre-implantation embryos [19-22]. Because of the protamine-histone transition that happens soon after fertilization, oocyte-derived unmodified histones embed into the paternal chromatin [23-26]. Thereafter newly synthesized modifications make the paternal and the maternal chromatin asymmetrically [24-26], which may contribute to the differences in de-methylation fates between the paternal and maternal genome. Immunofluorescence analysis demonstrate a consistent expression of several histone modifications, such as trimethylation on lysine 4 of histone 3 (H3K4me3), H3K27me3 and H3K9me2, in maternal pronuclear, while these modifications in paternal pronuclear gradually increase with the schedule of development in one-cell stage embryos (Figure 1) [20-22,27-29]. Although DNA demethylation and several histone modifications present similar patterns, there is no direct evidence proving similarity in them. Previous studies implicated that stella/PGC7 protected the maternal genome against from being demethylated and maintained the methylation level of several imprinted genes [30]. However, no bridge linking the histone modifications and DNA methylation was identified. Until 2012, based on their work published previously [30], Nakano’s group demonstrated that stella/PGC7, through binding to H3K9me2, could block Tet3’s binding to the maternal genome as well as several paternal imprinted genes, which protected them from active de-methylation [31]. This potential protection mechanism provides us with a better insight into this particular event, but more experiments are still required for a thorough understanding of it.
Imprinted XCI and its reactivation: When fertilization happens, the paternal X chromosome is inherited inactively, referred to as the imprinted XCI. This form of nonrandom XCI is initiated in embryos at the early cleavage stage and then maintained in extraembryonic tissues as well as their derivatives [32,33]. However, the imprintedly inactive paternal X chromosome is reactivated selectively in Inner Cell Mass (ICM) (Figure 1) [34]. Initiation of the imprinted XCI is dependent on the cis regulation of a long nocoding RNA – Xist, which coats the inactivated X chromosome [35]. Though the paternal X chromosome is inherited actively like the maternal X one [36], it soon becomes inactivated because of the expression of paternally originated Xist, which in turn wrap the paternal X chromosome up and leads to its silence; whereas the maternal Xist is repressed and not expressed until the morula stage [37]. During this period, the global genome is undergoing DNA demthylation, so DNA methylation may not likely participate in the imprinted XCI regulation. In addition, in Dnmt1-deficient embryos, imprinted XCI in extraembryonic tissues is not affected [38]. However, histone modifications alter dynamically. Immunofluorescence analysis demonstrated the accumulation of transcriptionally repressed markers, dimethylation of histone H3 lysine 9 (H3K9me2) and trimethylation of H3K27 (H3K27me3) starting from the 16-cell stage and continuing afterwards [39]. Additionally, hypoacetylation of H3K9 and hypomethylation of H3K4 were also detected from the 8-cell stage embryos [39], after the coating of Xist in Xp. These data indicates that Xist may cooperate with these modifications to regulate the activation of Xp. Indeed, recent work further reported an ncRNA (RepA) within Xist and identified it as a binding target for Polycomb Repressive Complex 2 (PRC2). RepA was demonstrated to be able to recruit PRC2 to the X chromosome, with Ezh2 serving as the binding subunit, ,then methylate lysine 27 on histone H3 [40] and subsequently silence the paternal X chromosome synergistically.
Albeit Xp is still inactive as determined by Xist coating, RNA Polymerase II (RNA Pol II) exclusion, H3K9 and H3K27 methylation as well as Eed/Enx1 accumulation at the early blastocyst stage [39], these depressed markers disappear late in the blastocyst stage [34,39]. This reactivation process resets cells in the ICM back to a pluripotent state and gets them ready for future lineage differentiation.
Epigenetic reprogramming in germ cells
DNA methylation reprogramming in germ cells: At the blastocyst stage, embryos possess a globally low level of DNA methylation. However, the epiblast as well as the early PGCs, return to a hypermethylated state due to the function of de novo methyltransferases upon implantation [4,10,41,42]. After E8.5, with the migration and proliferation of PGCs, a genome-wide loss of DNA methylation is detected (Figure 1) [43]. Prior to E9.5, DNA de-methylation occurs on promoters, CpG islands, exons, introns and intergenic regions [44-46]. But until PGCs enter the genital ridges, imprinted genes are not erased [47,48]. The de-methylation happens later (E10.5 thereafter) is an active process mediated by Tet1 and Tet2 proteins (Figure 1) [49-51]. Since DNA methylation erasure is achieved in a thorough way, it is believed that epigenetic information cannot be passed on into the next generation, for epimutations were erased and corrected in this process [52-54]. However, there are still a handful of elements, Intracisternal-A-Particles (IAPs) for example, who escape from the systematic de-methylation. And that may provide an insight into the transgenerational epigenetic inheritance [2,46,47,55,56].
Following the gender-determination (~E12.5), de novo DNA methylation takes place and new methylation landscapes are established in an asymmetrical pattern in male and female germ cell precursors. In male germ cells, de novo methylation initiates before the onset of meiosis, and finishes prior to birth. While in female germ cells, de novo methylation occurs during the postnatal development of meiotic prophase I - arrested oocytes (Figure 1). Additionally, bisulfite sequencing analysis identifies ~900 oocyte-specific Methylated CpG Islands (CGIs) and ~60 sperm-specific methylated CGIs [57], among which Germline Differently Methylated Regions (gDMRs) of imprinted genes are included.
Histone remodeling in germ cells: During the formation of germ cells, histone modifications change in accord with the DNA methylation dynamics. A signature is the gradual loss of H3K9me2 which starts from E7.5 and afterwards (Figure 1) [43] in a G9a/ EHMT2-independent way as G9a knockout does not affect the PGC specification [58]. However, it associates with the down regulation of GLP/EHMT1, which affects the G9a-GLP complex [59]. Another feature is the up regulation of H3K27me3 initiated at E8.5 that precede later on, concomitant with the accumulation of Ezh2 [43]. After PGCs enter the genital ridge, H3K4 methylation and H3K9 acetylation (H3K9ac), which are transcriptionally permissive, increase sharply [43], while transcriptionally repressive histone modifications, such as H3K9me3 and H3K27me3 are removed (Figure 1) [60]. These changes may make DNA demethylase accessible to the chromatin and achieve more extensive de-methylation, even on the imprinted gene loci [2,61].
Random XCI and its activation: Soon after implantation, the second wave of X chromosome inactivation and reactivation is initiated in parallel with to the genomic reprogramming occurring in PGCs [62]. At E4.5, the late blastocyst stage, the inactive X chromosome (Xi) is already reactivated (Figure 1). However, by E5.5, one of the two X chromosomes in most epiblast cells is chosen randomly to be inactivated by Xist, expressed either from the paternal or the maternal gene locus. The entire epiblast cells complete random X chromosome inactivation by E6.5, that is, the monoallelic expression of X-linked genes [63,64]. Since PGCs emerges after E6.25, marked by a PGC progenitors expressing protein, Blimp1 [65], it is indubitable that PGCs have undergone X chromosome inactivation before germ cell specification. Apart from the Xist coating, the nuclear accumulation of H3K27me3 participating in silencing X-linked gene expression was also detected by immunofluorescence staining [66].
With their migration and entry into the genital ridge, PGCs experience a Xi reactivation, which enable them ready for germ cell specification, for the X chromosomes in oocytes are active. FISH analysis revealed that decreased Xist expression beginning at ~E7.0, and reaching an undetectable level at ~E10.5 [67]. And there is a dramatic decline in H3K27me3 level from E7.5 to E9.5 [66]. However, even though X-linked genes initiate their biallelic expression from ~E7.75, they do not accomplish a thorough activation until E14.5 revealed by quantitative reverse transcription polymerase chain reaction (qRTPCR) [66,67].
Compared with the reactivation in ICM, resetting the randomly inactivated Xi is a time-consuming event. These differences may account for the involvement of different epigenetic remodeling that in PGCs it is a passive process requiring several cell divisions [66,67], while in ICM it is completed in one day [34,39]. The possibility is that in PGCs, Xist silences the X chromosome cooperating with DNA methylation as well as histone modifications [38,66,67], while in ICM no DNA methylation involved [38,43], making it possible for the erasure accomplished rapidly.
Conclusion
Epigenetic reprogramming in the early embryogenesis and germ cells specification progress is complicated. Previous works have identified DNA methylase (Dnmt1, Dnmt3a and Dnmt3b) and DNA demethylases (Tet1, Tet2 and Tet3), and their function mechanisms have been revealed. However, when it comes to the complex biological processes, we know a little. Though it was demonstrated that H3K9me2 can protect the maternal genome and several imprinted genes from active de-methylation, this mechanism was not adapted to all the conditions. In addition, there indeed are regulatory elements escape de-methylation in PGCs [49,55] and epigenetic modification induced phenotype inheritable [68,69]. But no direct experimental evidence is given that epigenetic modifications/epimutations can be germline transmitted in mouse [52,54] as it is proven in zebrafish [70]. How DNA methylation and histone modifications interact with each other and function cooperatively is only a tip of the iceberg. To have a more comprehensive and thorough acknowledged of the epigenetic reprogramming, more works are still needed, which will deepen our understanding of the developmental regulation mechanisms.
Acknowledgements
This study was supported by grants from the “Strategic Priority Research Program” of the Chinese Academy of Sciences XDA01020100 (to Q.Z.) and the China National Basic Research Program 2012CBA01300 (to Q.Z.), and grant from the National Science Foundation of China 90919060 (to Q.Z).
References
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11274
  • [From(publication date):
    December-2013 - Aug 26, 2016]
  • Breakdown by view type
  • HTML page views : 7538
  • PDF downloads :3736
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version